Pages that link to "Q34296575"
Jump to navigation
Jump to search
The following pages link to EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy (Q34296575):
Displaying 50 items.
- Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer (Q24658633) (← links)
- Fundamentals of cancer metabolism (Q26744062) (← links)
- Novel delivery strategies for glioblastoma (Q27006099) (← links)
- Identification and dissection of four major QTL affecting milk fat content in the German Holstein-Friesian population (Q27334230) (← links)
- p53 as a Regulator of Lipid Metabolism in Cancer (Q28079393) (← links)
- The multifaceted roles of fatty acid synthesis in cancer (Q29694341) (← links)
- Lipid metabolism emerges as a promising target for malignant glioma therapy (Q30684049) (← links)
- Non-invasive metabolic imaging of brain tumours in the era of precision medicine (Q31115540) (← links)
- Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression (Q33779353) (← links)
- mTORC2 in the center of cancer metabolic reprogramming (Q33831466) (← links)
- Role of receptor tyrosine kinases and their ligands in glioblastoma (Q33883849) (← links)
- Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies (Q33925544) (← links)
- Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment (Q33955139) (← links)
- mTOR signaling in glioblastoma: lessons learned from bench to bedside (Q34133033) (← links)
- Inhibition of fatty acid synthase induces pro-survival Akt and ERK signaling in K-Ras-driven cancer cells (Q34223118) (← links)
- A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study (Q34582560) (← links)
- Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance. (Q34974398) (← links)
- A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas (Q35102261) (← links)
- Metabolic state of glioma stem cells and nontumorigenic cells (Q35229102) (← links)
- Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients (Q35640624) (← links)
- Arsenic trioxide sensitizes glioblastoma to a myc inhibitor. (Q35650870) (← links)
- Significance of filamin A in mTORC2 function in glioblastoma (Q35809950) (← links)
- Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastoma (Q35837389) (← links)
- Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. (Q36062158) (← links)
- Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient (Q36062188) (← links)
- Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR (Q36090422) (← links)
- Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells (Q36189861) (← links)
- Diacylglycerol kinase-ζ regulates mTORC1 and lipogenic metabolism in cancer cells through SREBP-1 (Q36245893) (← links)
- Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells. (Q36247876) (← links)
- mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment (Q36256815) (← links)
- Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth (Q36275975) (← links)
- Complex Oncogenic Signaling Networks Regulate Brain Tumor‐Initiating Cells and Their Progenies: Pivotal Roles of Wild‐Type EGFR, EGFRvIII Mutant and Hedgehog Cascades and Novel Multitargeted Therapies (Q36280796) (← links)
- Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake (Q36337964) (← links)
- Regulation of cholesterol biosynthesis and cancer signaling (Q36418517) (← links)
- Sugar Makes Fat by Talking to SCAP (Q36634441) (← links)
- The multifaceted role of mTORC1 in the control of lipid metabolism (Q36659049) (← links)
- PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies (Q36693019) (← links)
- De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients (Q36836744) (← links)
- Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity (Q36839721) (← links)
- EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer (Q36920081) (← links)
- Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma (Q37088201) (← links)
- Cellular fatty acid metabolism and cancer (Q37092913) (← links)
- Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth. (Q37168356) (← links)
- The Hippo pathway, p53 and cholesterol (Q37216964) (← links)
- Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development (Q37287417) (← links)
- SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer (Q37289439) (← links)
- Lipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung Cancer (Q37339704) (← links)
- An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity (Q37573880) (← links)
- Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies (Q37610799) (← links)
- mTOR links oncogenic signaling to tumor cell metabolism (Q37837598) (← links)